Latest news

Research carried out at Instituto Bernabeu links the result of the β-hCG with the prognosis of the pregnancy

  • 07/01/20

2020 events conditioned the congress of the European Society of Human Reproduction and Embryology (ESHRE) to be held online for the first time in history. Among different research projects developed at Instituto Bernabeu that its scientific committee has accepted to share with the community, there is a report on the evaluation of the β-hCG pregnancy hormone value as a predictor of the evolution of the pregnancy

Read more

New research from Instituto Bernabeu based on the use of micronized natural progesterone versus GnRH antagonists in egg donation cycles.

  • 06/17/20

Dr. Juan Carlos Castillo will present an Oral Communication at the next ESHRE Meeting of the latest research paper “Natural micronized progesterone versus a GnRH antagonist in egg-donation cycles. An extended experience ”; a new advance to improve medication in egg donors.

The current circumstances have made this scientific event, the most important in the field of Reproductive Medicine, to be held extraordinarily online this year.

Read more

Instituto Bernabeu participates in the creation of the first oficial ultrasound guide for Reproductive Medicine

  • 06/03/20

Instituto Bernabeu has participated in the creation of the Guide to Practical Care of the Obstetric and Gynecological Ultrasound section of the Spanish Society of Obstetrics and Gynecology.

Read more

Upsala Journal of Medical Sciences prints a review carried out by Instituto Bernabeu regarding the role of GnRHa as ovulation induction, more than just to prevent hyperstimulation.

  • 05/27/20

Optimizes and improves cycles for egg donors, oncology patients, women with low reserve, immature oocyte syndrome and empty follicle syndrome

The international medical journal Upsala Journal of Medical Sciences has just published a research paper led by Instituto Bernabeu entitled "Gonadotropin-releasing hormone agonist ovulation trigger — beyond OHSS prevention". It was developed by Instituto Bernabeu gynecologist, expert in ovarian stimulation, Dr. Juan Carlos Castillo with the participation of Thor Haahr, María Martínez-Moya and Peter Humaidan. The goal of this review is to present the advantages of the gonadotropin-releasing hormone agonist (GnRHa) trigger in ovarian stimulation during reproductive medicine treatment. It highlights that its role goes beyond the prevention of ovarian hyperstimulation syndrome (OHSS).

Read more